Skip to main content
OpenTrials
Completed

NCT Number: NCT07176598

Rare Case of Misdiagnosed Primary Intramuscular Hydatid Cyst of the Deltoid Muscle

This case report describes a rare parasitic cyst called a hydatid cyst located in the shoulder muscle (deltoid) of a 29-year-old male. The patient initially presented with a painless, gradually enlarging swelling over the left shoulder. It was misdiagnosed as a synovial cyst and treated with corticosteroids, which caused local inflammation and purulent discharge. Blood tests for Echinococcus antibodies were negative. Ultrasound and MRI revealed a well-defined intramuscular cyst confined to the deltoid muscle. Surgical excision confirmed the diagnosis, and the patient received postoperative albendazole therapy for three months. Follow-up showed complete healing, restoration of shoulder function, and no recurrence. This case highlights the importance of considering hydatid disease in unusual muscle locations, particularly in endemic areas, to avoid misdiagnosis and ensure proper treatment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–120 year

Sex eligibility

Male

Study type

Observational

Primary location

Al-Shahbaa Specialized Hospital

Aleppo, Syria

About this study

This report presents a rare case of a primary intramuscular hydatid cyst confined to the deltoid muscle in a 29-year-old male. The patient had a seven-month history of a gradually enlarging swelling in the left shoulder. Initially misdiagnosed as a synovial cyst, he received corticosteroid injection, which led to pain, erythema, and purulent discharge. Physical examination revealed a 10 cm fluctuant mass over the posterolateral deltoid. Serology for Echinococcus antibodies was negative. Ultrasound showed a well-defined, anechoic intramuscular cyst measuring 7 × 8 × 10 cm. MRI confirmed a fluid-filled cyst confined to the deltoid muscle, without involvement of bone, tendon, or joint structures. Under local anesthesia, the cyst was completely excised, and the cavity was irrigated with 10% povidone-iodine. Histopathology confirmed a non-fertile hydatid cyst (Echinococcus granulosus) without malignancy. Postoperative therapy included albendazole 400 mg daily for three months. Follow-up at six weeks showed complete wound healing, full shoulder function, and no recurrence. This case underscores the diagnostic challenges of intramuscular hydatid cysts, especially with negative serology, and highlights the importance of imaging, histopathology, and careful surgical management in endemic regions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male patient Age 18 years or older Diagnosed with primary intramuscular hydatid cyst of the deltoid muscle

Exclusion criteria

Patients with cysts in other organs (liver, lungs) Patients with systemic infection or immunocompromised status Patients who did not undergo surgical excision

-

Treatment and study plan

Primary outcomes

  1. Complete recovery of shoulder function without recurrence

    Time frame: 6 weeks postoperatively

    Monitoring for surgical site infection, serological status, and general patient well-being following treatment.

Sponsors and collaborators

Lead sponsor

Al-Shahba Specialized Hospital

Other

Registry information

Official study title

Case Report: Misdiagnosed Primary Intramuscular Hydatid Cyst of the Deltoid Muscle in a Male Patient

Acronym: RPHC-Deltoid

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Sep 16, 2025
Registry last updated
Sep 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.